Home » Author Archive
Celestica (NYSE:CLS) Shares Climb 8.2% – Here’s What Happened
Celestica, Inc. (NYSE:CLS – Get Free Report) (TSE:CLS)’s share price shot up 8.2% during mid-day trading on Monday. The stock traded as high as $225.26 and last traded at $223.6240. Approximately 4,631,549 shares were traded... More of this article »
VanEck Semiconductor ETF (NASDAQ:SMH) Shares Up 5.1% – Still a Buy?
VanEck Semiconductor ETF (NASDAQ:SMH – Get Free Report)’s share price rose 5.1% during trading on Monday. The stock traded as high as $490.47 and last traded at $487.41. 14,558,745 shares traded hands during trading, an... More of this article »
Advanced Micro Devices (NASDAQ:AMD) Shares Climb 13.3% – Still a Buy?
Advanced Micro Devices, Inc. (NASDAQ:AMD – Get Free Report)’s stock price rose 13.3% during mid-day trading on Monday. The company traded as high as $515.18 and last traded at $508.58. Approximately 50,752,665 shares traded... More of this article »
Applied Materials (NASDAQ:AMAT) Shares Climb 6.1% – Here’s What Happened
Applied Materials, Inc. (NASDAQ:AMAT – Get Free Report)’s stock price was up 6.1% on Wednesday. The stock traded as high as $404.71 and last traded at $395.08. 7,280,220 shares were traded during trading, a decline of 8%... More of this article »
D-Wave Quantum (NASDAQ:QBTS) Stock Jumps 1.6% – Time to Buy?
D-Wave Quantum Inc. (NASDAQ:QBTS – Get Free Report) shares shot up 1.6% during trading on Wednesday. The stock traded as high as $11.02 and last traded at $10.65. 14,596,715 shares were traded during mid-day trading, a decline... More of this article »
What Compugen (CGEN) Said on Its Q3 Earnings Call
Compugen (NASDAQ:CGEN) has completed enrollment in a randomized trial of its ovarian cancer treatment candidate COM701 and expects to report results by the end of the first quarter of 2027, executives said on the company’s third-quarter... More of this article »
What Lassonde Industries (LAS.A) Said on Its Q3 Earnings Call
Lassonde Industries (TSE:LAS.A) reported higher third-quarter gross profit and adjusted earnings per share despite lower sales, as production disruptions at two U.S. beverage plants and weak category volumes weighed on the business. Sales... More of this article »
Microsoft (NASDAQ:MSFT) Shares Down 2.3% Following Insider Selling
Microsoft Corporation (NASDAQ:MSFT – Get Free Report) shares fell 2.3% on Wednesday following insider selling activity. The stock traded as low as $518.45 and last traded at $521.13. Approximately 28,379,817 shares changed hands... More of this article »
American Financial Group (NYSE:AFG) Reaches New 52-Week High – Here’s Why
Shares of American Financial Group, Inc. (NYSE:AFG – Get Free Report) hit a new 52-week high during trading on Wednesday. The company traded as high as $161.31 and last traded at $161.1940, with a volume of 496,256 shares. The... More of this article »
UBS Group Issues Positive Forecast for Kimco Realty (NYSE:KIM) Stock Price
Kimco Realty (NYSE:KIM – Get Free Report) had its price objective raised by research analysts at UBS Group from $25.00 to $29.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently... More of this article »
UBS Group Issues Positive Forecast for Regency Centers (NASDAQ:REG) Stock Price
Regency Centers (NASDAQ:REG – Get Free Report) had its price objective lifted by analysts at UBS Group from $77.00 to $82.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage... More of this article »
Analyzing MDxHealth (NASDAQ:MDXH) and BioCardia (NASDAQ:BCDA)
BioCardia (NASDAQ:BCDA – Get Free Report) and MDxHealth (NASDAQ:MDXH – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of... More of this article »
Critical Review: Zevra Therapeutics (NASDAQ:ZVRA) and Eloxx Pharmaceuticals (NASDAQ:ELOX)
Zevra Therapeutics (NASDAQ:ZVRA – Get Free Report) and Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies... More of this article »
TransUnion (TRU) & Its Rivals Critical Review
TransUnion (NYSE:TRU – Get Free Report) is one of 203 public companies in the “Professional Services” industry, but how does it compare to its rivals? We will compare TransUnion to related businesses based on the... More of this article »
Reviewing Alta Equipment Group (ALTG) and The Competition
Alta Equipment Group (NYSE:ALTG – Get Free Report) is one of 157 publicly-traded companies in the “Trading Companies & Distributors” industry, but how does it contrast to its peers? We will compare Alta Equipment... More of this article »
Brixmor Property Group (NYSE:BRX) Stock Price Expected to Rise, UBS Group Analyst Says
Brixmor Property Group (NYSE:BRX – Get Free Report) had its price target lifted by research analysts at UBS Group from $33.00 to $35.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “buy”... More of this article »
Intact Financial Q3 Earnings Call Highlights
Intact Financial (TSE:IFC) reported third-quarter net operating income of CAD 3.63 per share and a 94% combined ratio, as catastrophe losses exceeded expectations but premium growth improved across its businesses. The insurer’s... More of this article »
HSBC Targets U.K. Growth as Middle-Market Lending Jumps 15%
HSBC (NYSE:HSBC) plans to expand its U.K. commercial and retail businesses through digital investment and selective lending, while maintaining pricing discipline in a competitive deposit market, executives said at an investor breakfast. David... More of this article »
UBS Group Has Lowered Expectations for Transdigm Group (NYSE:TDG) Stock Price
Transdigm Group (NYSE:TDG – Get Free Report) had its target price reduced by equities researchers at UBS Group from $1,509.00 to $1,481.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has a “buy”... More of this article »
Evolv (NASDAQ: EVLV) ARR grows twice as fast as revenue, but net loss widens
What happened Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) grew annual recurring revenue (ARR) 20% to $140.5 million in the third quarter. Revenue grew 10%. ARR is the number that shows whether Evolv is a subscription business.... More of this article »
UBS Group Has Lowered Expectations for Aramark (NYSE:ARMK) Stock Price
Aramark (NYSE:ARMK – Get Free Report) had its price objective decreased by equities researchers at UBS Group from $71.00 to $65.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has... More of this article »
Kamada Q3 Earnings Call Highlights
Kamada (NASDAQ:KMDA) raised its 2026 revenue and adjusted EBITDA guidance after reporting double-digit third-quarter growth, as demand increased for its KEDRAB rabies treatment and other products. On the company’s November 9 earnings... More of this article »
National Energy Services Reunited (NASDAQ:NESR) Stock Price Down 5.3% – Time to Sell?
Shares of National Energy Services Reunited (NASDAQ:NESR – Get Free Report) dropped 5.3% on Monday. The company traded as low as $18.83 and last traded at $18.8950. Approximately 1,440,473 shares changed hands during mid-day... More of this article »